| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8738812 | International Journal of Infectious Diseases | 2018 | 14 Pages |
Abstract
Various platforms have been evaluated in humans, including Ad26, Ad5, ChimpAd3, DNA, MVA, and VSV. In addition to platforms, viral strain used for antibody detection influences antibody response. However, variability remained mostly unexplained. Therefore, comparison of vaccine immunogenicity needs randomised controlled trials.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Lise Gross, Edouard Lhomme, Chloé Pasin, Laura Richert, Rodolphe Thiebaut,